Amgen gets approval for two plants

09/7/2005 | Reuters

Amgen said the FDA approved new manufacturing plants, with Amgen's Enbrel to be produced at a plant in Rhode Island and Neupogen and Neulasta to be manufactured at a new plant in Puerto Rico. The company also said it was building a second facility at the Puerto Rico site for production of its anemia drug, Epogen.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN